This project is part of the EDCTP3 programme supported by the European Union

SAFIRE partners

Amsterdam UMC is a leading medical center that combines complex high-quality patient care, innovative scientific research and the education of the next generation of healthcare professionals.

CRUN aims to accelerate malaria control in Africa through clinical research and training and has contributed to the development of new malaria control and elimination tools such as vaccines, drugs, diagnostics and more.

IDRC builds research capacity through training, technology advancement and health service infrastructure upgrades; conducts research into infectious diseases such as malaria, HIV/AIDS and tuberculosis; disseminates research results; and promotes an evidence-based approach to policymaking by linking researchers and policymakers.

KEMRI is a regional and global leader in human health research and aims to improve human health and quality of life through research, capacity building, innovation and service delivery.

LSTM’s mission is to improve health outcomes in underserved populations globally through partnerships in research and education and has been at the forefront of research into infectious, debilitating and disabling diseases worldwide since 1898.

MMV is a product development partnership in antimalarial drug research and development. It has helped create the world’s largest antimalarial drug development portfolio and supports activities to ensure access to medicines for the most vulnerable.

The largest state university in the DRC, UNIKIN’s Department of Tropical Medicine is dedicated to conducting quality research and has been involved in several malaria and Ebola vaccine development projects.

The USTTB trains undergraduate to doctorate-level students in the field of science and technology. The International Center for Excellence in Research (ICER) and Malaria Research and Training Center (MRTC) are both part of the USTTB and conduct studies and clinical trials in the areas of malaria and other parasitic and viral diseases.

Subscribe to the SAFIRE newsletter

* indicates required

Please select all the ways you would like to hear from :

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.